Open Access
Issue
OCL
Volume 23, Number 4, July-August 2016
Article Number D405
Number of page(s) 15
Section Dossier: How might oilseeds help meet the protein challenge? / Comment les oléoprotéagineux peuvent-ils répondre au défi protéines ?
DOI https://doi.org/10.1051/ocl/2016025
Published online 10 August 2016
  • AFSSA (Agence française de sécurité sanitaire des aliments). 2005. Sécurité et bénéfices des phyto-estrogènes apportés par l’alimentation – Recommandations. Rapport mars 2005. Disponible sur : http://www.afssa.fr/Documents/NUT-Ra-Phytoestrogenes.pdf [Google Scholar]
  • American Academy of Pediatrics. 1998. Soy Protein-based Formulas; recommendations for use in infant feeding. Pediatrics 101 : 148–153. [CrossRef] [PubMed] [Google Scholar]
  • American Institute for Cancer Research. 2012. Soy is safe for breast cancer survivors. Disponible sur : www.aicr.org/cancer-research-update/2012/november_21_2012/cru-soy-safe.html [Google Scholar]
  • Anderson JW, Hohnstone BM, Cokk-Neweil ME. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. New Engl. J. Med. 333 : 276–382. [CrossRef] [Google Scholar]
  • Anderson JW, Bush HM. 2011. Soy protein effectson serum lipoproteins : a quality assessment and meta-analysis of randomized, controlled studies. J. Am. Coll. Nutr. 30 : 79–91. [CrossRef] [PubMed] [Google Scholar]
  • Andres A, Moore MB, Linam LE, et al. 2015. Compared with feeding infants breast milk or cow-milk formula, soy formula feeding does not affect subsequent reproductive organ size at 5 years of age. J. Nutr. 145 : 871–875. [CrossRef] [PubMed] [Google Scholar]
  • Bakhit RM, Klein BP, Essex-Sorlie D, et al. 1994. Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations. J. Nutr. 124 : 213–222. [CrossRef] [PubMed] [Google Scholar]
  • Beaton LK, McVeigh BL, Dillingham BL, Lampe JW, Duncan AM. 2010. Soy protein isolates of varying isoflavone content do not adversely affect semen quality in healthy young men. Fertil. Steril. 94 : 1717–1722. [CrossRef] [PubMed] [Google Scholar]
  • Beavers DP, Beavers KM, Miller M, et al. 2012. Exposure to isoflavone-containing soy products and endothelial function : a Bayesian meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 22 : 182–191. [CrossRef] [PubMed] [Google Scholar]
  • Benkhedda KB, B, Sinclair SE, Marles RJ, et al. 2014. Food Risk Analysis Communication. Issued By Health Canada’s Food Directorate. Health Canada’s Proposal to Accept a Health Claim about Soy Products and Cholesterol Lowering. Int. Food. Risk Anal. J. 4 : 22. [Google Scholar]
  • Biro FM, Galvez MP, Greenspan LC, et al. 2010. Pubertal Assessment Method and Baseline Characteristics in a Mixed Longitudinal Study of Girls. Pediatrics. [Google Scholar]
  • Bray F, Mc Carron P,Parkin DM. 2004. The changing global patterns of female breast cancer incidence and mortality. Breast. Cancer Res. 6 : 229–239. [CrossRef] [PubMed] [Google Scholar]
  • Caan BJ, Natarajan L, Parker B, et al. 2011. Soy food consumption and breast cancer prognosis. Cancer Epidemiol. Biomark. Prev. 20 : 854–858. [CrossRef] [Google Scholar]
  • Charland SL, Malone DC. 2010. Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy. Curr. Med. Res. Opin. 26 : 365–375. [CrossRef] [PubMed] [Google Scholar]
  • Chavarro JE, Toth TL, Sadio SM, Hauser R. 2008. Soy food and isoflavone intake in relation to semen quality parameters among men from an infertility clinic. Hum. Reprod. 23 : 2584–2590. [CrossRef] [PubMed] [Google Scholar]
  • Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG. 2013. Post-diagnosis soy food intake and breast cancer survival : A meta-analysis of cohort studies. Asian Pac. J. Cancer Prev. 14 : 2407–2412. [CrossRef] [PubMed] [Google Scholar]
  • COT. 2003. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. Phytoestrogens and Health. May 2003, rapport disponible sur le site Internet de la FSA-UK. Disponible sur : http://cot.food.gov.uk/sites/default/files/cot/phytoreport0503.pdf [Google Scholar]
  • Demonty I, Lamarche B, Peter J.H, Jones PD. 2003. Role of isoflavones in the hypocholesterolemic effect of soy. Nutr. Rev. 61 : 189–203. [CrossRef] [PubMed] [Google Scholar]
  • Dong JY, Qin LQ. 2011. Soy isoflavones consumption and risk of breast cancer incidence or recurrence : a meta-analysis of prospective studies. Breast. Cancer Res. Treat. 125 : 315–323. [CrossRef] [PubMed] [Google Scholar]
  • Dong JY, Tong X, Wu ZW, et al. 2011. Effect of a soya protein on blood pressure : a meta-analysis of randomised controlled trials. Br. J. Nutr. 106 : 1–10. [CrossRef] [Google Scholar]
  • EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA). 2010. Scientific Opinion on Dietary Reference Values for carbohydrates and dietary fibre. EFSA J. 8 : 1462. [Google Scholar]
  • EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA). 2011. Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL-cholesterol concentrations pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 9 : 2069. [Google Scholar]
  • EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA). 2012. Scientific Opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J. 10 : 2555. [Google Scholar]
  • EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). 2015. Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones. EFSA J. 13 : 4246. [Google Scholar]
  • Euling SY, Herman-Giddens ME, Lee PA, et al. 2008. Examination of US puberty-timing data from 1940 to 1994 for secular trends : panel findings. Pediatrics 121 : S172-S191. [CrossRef] [PubMed] [Google Scholar]
  • FAO (Food and Agriculture Organization of the United Nations). 2013. Dietary protein quality evaluation in human nutrition. Report of an FAO Expert Consultation. FAO Food and Nutrition Paper 92, Rome, 2013. [Google Scholar]
  • FDA. 1999. Food Labeling : Health Claims; Soy Protein and Coronary Heart Disease. In : Federal Register, 1999, Vol. 64, No. 206, 57699–57733. [Google Scholar]
  • Gilani GS, Cockell KA, Sepehr E. 2005. Effects of antinutritional factors on protein digestibility and amino acid availability in foods. J. AOAC Int. 88 : 967–87. [PubMed] [Google Scholar]
  • Guha N, Kwan ML, Quessenberry CP Jr, et al. 2009. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors : the Life After Cancer Epidemiology study. Breast. Cancer Res. Treat. 118 : 395–405. [CrossRef] [PubMed] [Google Scholar]
  • Gu L, House SE, Prior RL, et al. 2006. Metabolic phenotypes of isoflavones differ among female rats, pigs, monkeys, and women. J. Nutr. 136 : 1215–1221. [CrossRef] [PubMed] [Google Scholar]
  • Gunther AL, Karaolis-Danckert N, Kroke A, Remer T, Buyken AE. 2010. Dietary protein intake throughout childhood is associated with the timing of puberty. J. Nutr. 140 : 565–571. [CrossRef] [PubMed] [Google Scholar]
  • Hamilton-Reeves JM, Vazquez G, Duval SJ, Phipps WR, Kurzer MS, Messina MJ. 2010. Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men : results of a meta-analysis. Fertil. Steril. 94 : 997–1007. [CrossRef] [PubMed] [Google Scholar]
  • Harland JI, Haffner TA. 2008. Systematic review, meta-analysis and regression of randomized controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis 200 : 13–27. [CrossRef] [PubMed] [Google Scholar]
  • Heaney RP, Weaver CM, Fitzsimmons ML. 1991. Soybean phytate content : effect on calcium absorption. Am. J. Clin. Nutr. 53 : 745–747. [CrossRef] [PubMed] [Google Scholar]
  • Hooper L, Kroon PA, Rimm EB, et al. 2008. Flavonoids, flavonoid-rich foods, and cardiovascular risk : a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88 : 38–50. [CrossRef] [PubMed] [Google Scholar]
  • Hooper L, Ryder JJ, Kurzer MS, et al. 2009. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women : a systematic review and meta-analysis. Hum. Reprod. Update 15 : 423–440. [CrossRef] [PubMed] [Google Scholar]
  • Hooper L, Madhavan G, Tice JA, Leinster SJ, Cassidy A. 2010. Effects of isoflavones on breast density in pre- and post-menopausal women : a systematic review and meta-analysis of randomized controlled trials. Hum. Reprod. Update 16 : 745–760. [CrossRef] [PubMed] [Google Scholar]
  • Hughes GJ, Ryan DJ, Mukherjea R, Schasteen CS. 2011. Protein digestibility-corrected amino acid scores (PDCAAS) for soy protein isolates and concentrate : Criteria for evaluation. J. Agric. Food Chem. 59 : 12707–12712. [CrossRef] [PubMed] [Google Scholar]
  • Jenkins DJ, Kendall CW, Faulkner D, et al. 2002. A dietary portfolio approach to cholesterol reduction : combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 51 : 1596–604. [CrossRef] [PubMed] [Google Scholar]
  • Jenkins DJ, Kendall CW, Marchie A et al. 2003. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290 : 502–10. [CrossRef] [PubMed] [Google Scholar]
  • Jenkins DJ, Josse AR, Wong JM, et al. 2007. The portfolio diet for cardiovascular risk reduction. Curr. Atherosc. Rep. 9 : 501–507. [CrossRef] [Google Scholar]
  • Jenkins DJ, Jones PJ, Frohlich J, et al. 2015. The effect of a dietary portfolio compared to a DASH-type diet on blood pressure. Nutr. Metab. Cardiovasc. Dis. 25 : 1132–1139. [CrossRef] [PubMed] [Google Scholar]
  • Kang X, Zhang Q, Wang S, Huang X, Jin S. 2010. Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. CMAJ 182 : 1857–1862. [CrossRef] [PubMed] [Google Scholar]
  • Khan SA, Chatterton RT, Michel N, et al. 2012. Soy isoflavone supplementation for breast cancer risk reduction : A randomized phase II trial. Cancer Prev. Res. (Phila.) 5 : 309–319. [CrossRef] [Google Scholar]
  • Korde LA, Wu AH, Fears T, et al. 2009. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol. Biomark. Prev. 18 : 1050–1059. [CrossRef] [Google Scholar]
  • Kuiper GG, Carlsson B, Grandien K, et al. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 : 863-870. [PubMed] [Google Scholar]
  • Kuiper GG, Lemmen JG, Carlsson B, et al. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 : 4252-4223. [PubMed] [Google Scholar]
  • Lammi C, Zanoni C, Arnoldi A, Vistoli G. 2015. Two peptides from soy beta-conglycinin induce a hypocholesterolemic effect in HepG2 cells by a statin-like mechanism : Comparative in vitro and in silico modeling studies. J. Agric. Food Chem. 63 : 7945–7951. [CrossRef] [PubMed] [Google Scholar]
  • Lecerf J.M.,Borgies B. 2002. Effects of soybean oil on plama lipoproteins and cardiovascular risk of men and women. OCL 9 : 96–99. [CrossRef] [EDP Sciences] [Google Scholar]
  • Lee SA, Shu XO, Li H, et al. 2009. Adolescent and adult soy food intake and breast cancer risk : results from the Shanghai Women’s Health Study. Am. J. Clin. Nutr. 89 : 1920–1926. [CrossRef] [PubMed] [Google Scholar]
  • Liu XX, Li SH, Chen JZ et al. 2012. Effect of soy isoflavones on blood pressure : a meta-analysis of randomized controlled trials. Nutr. Metabl. Cardiovasc. Dis. 22 : 463–470. [CrossRef] [Google Scholar]
  • Lovati MR, Manzoni C, Gianazza E, et al. 2000. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J. Nutr. 130 : 2543–2549. [CrossRef] [PubMed] [Google Scholar]
  • Lundh TJ-O, Petterson HL, Martinsson KA. 1990. Comparative levels of free and conjugated plant estrogens in blood plasma of sheep and cattle fed estrogenic silage. J. Agric. Food Chem. 38 : 1530–1534. [CrossRef] [Google Scholar]
  • Messina MJ, Wood CE. 2008. Soy isoflavones, estrogen therapy, and breast cancer risk : analysis and commentary. Nutr. J. 7 : 17. [CrossRef] [PubMed] [Google Scholar]
  • Minguez-Alarcon L, Afeiche MC, Chiu YH, et al. 2015. Male soy food intake was not associated with in vitro fertilization outcomes among couples attending a fertility center. Andrology 3 : 702–8. [CrossRef] [PubMed] [Google Scholar]
  • Mitchell JH, Cawood E, Kinniburgh D, Provan A, Collins AR, Irvine DS. 2001. Effect of a phytoestrogen food supplement on reproductive health in normal males. Clin. Sci. (Lond.) 100 : 613–618. [CrossRef] [Google Scholar]
  • Nechuta SJ, Caan BJ, Chen WY, et al. 2012. Soy food intake after diagnosis of breast cancer and survival : an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am. J. Clin. Nutr. 96 : 123–32. [CrossRef] [PubMed] [Google Scholar]
  • Palomares MR, Hopper L, Goldstein L, Lehman CD, Storer BE, Gralow JR. 2004. Effect of soy isoflavones on breast proliferation in postmenopausal breast cancer survivors. Breast. Cancer Res. Treat. 88 : 4002. [Google Scholar]
  • Parkin D.M., Whelan S.L., Ferlay J. 1997. Cancer incidence in five continents. Lyon (France) : by International Agency for research on Cancer, Vol. VIII. [Google Scholar]
  • Ramprasath VR, Jenkins DJ, Lamarche B, et al. 2014. Consumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds. Nutr. J. 13 : 101. [CrossRef] [PubMed] [Google Scholar]
  • Redmon JM, Shrestha B, Cerundolo R, Court MH. 2015. Soy isoflavone metabolism in cats compared with other species : urinary metabolite concentrations and glucuronidation by liver microsomes. Xenobiotica 1–10. [Google Scholar]
  • Reynolds K, Chin A, Lees KA et al. 2006. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am. J. Cardiol. 98 : 633–40. [CrossRef] [PubMed] [Google Scholar]
  • Rock CL, Doyle C, Demark-Wahnefried W, et al. 2012. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J. Clin. 62 : 242–74. [CrossRef] [Google Scholar]
  • Rogers IS, Northstone K, Dunger DB, Cooper AR, Ness AR, Emmett PM. 2010. Diet throughout childhood and age at menarche in a contemporary cohort of British girls. Public Health Nutr. 1–12. [Google Scholar]
  • Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. 2000. Interindividual variation in metabolism of soy isoflavones and lignans : influence of habitual diet on equol production by the gut microflora. Nutr. Cancer. 36 : 27–32. [CrossRef] [PubMed] [Google Scholar]
  • Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. 2003. Bioavailability of phyto-oestrogens. Br. J. Nutr. 89 : S45-S58. [PubMed] [Google Scholar]
  • Ruhrah J. 1909. The soy bean in infant feeding : preliminary report. Arch. Pediatr. 26 : 496–501. [Google Scholar]
  • Rutherfurd SM, Fanning AC, Miller BJ, Moughan PJ. 2015. Protein digestibility-corrected amino acid scores and digestible indispensable amino acid scores differentially describe protein quality in growing male rats. J. Nutr. 145 : 372–379. [CrossRef] [PubMed] [Google Scholar]
  • Sartippour MR, Rao JY, Apple S, et al. 2004. A pilot clinical study of short-term isoflavone supplements in breast cancer patients. Nutr. Cancer. 49 : 59–65. [CrossRef] [PubMed] [Google Scholar]
  • Segovia-Siapco G, Pribis P, Messina M, Oda K, Sabate J. 2014. Is soy intake related to age at onset of menarche? A cross-sectional study among adolescents with a wide range of soy food consumption. Nutr. J. 13 : 54. [CrossRef] [PubMed] [Google Scholar]
  • Setchell KD, Gosselin SJ, Welsh MB, et al. 1987. Dietary estrogens–a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 93 : 225–233. [CrossRef] [PubMed] [Google Scholar]
  • Setchell KD, Brown NM, Lydeking-Olsen E. 2002. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 132 : 3577–3584. [CrossRef] [PubMed] [Google Scholar]
  • Setchell KD, Brown NM, Zhao X, et al. 2011. Soy isoflavone phase II metabolism differs between rodents and humans : implications for the effect on breast cancer risk. Am. J. Clin. Nutr. 94 : 1284–94. [CrossRef] [PubMed] [Google Scholar]
  • Shike M, Doane AS, Russo L, et al. 2014. The effects of soy supplementation on gene expression in breast cancer : a randomized placebo-controlled study. J. Natl. Cancer Inst. 106, doi :10.1093/jnci/dju189. [Google Scholar]
  • Shu X.O., Jin F., Daï Q., et al. 2001. Soy food intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidem. Biomark. Prev. 10 : 483–488. [Google Scholar]
  • Shu XO, Zheng Y, Cai H, et al. 2009. Soy food intake and breast cancer survival. JAMA 302 : 2437–2443. [CrossRef] [PubMed] [Google Scholar]
  • Sojaxa. 2015. Rapport d’étude Quali-Quanti « Les Français et les aliments au soja », 12 janvier 2015. [Google Scholar]
  • Soukup ST, Helppi J, Müller DR, et al. 2016. Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice : a cross-species and sex comparison. Arch. Toxicol. 90 : 1335–1347. [CrossRef] [PubMed] [Google Scholar]
  • Stanford J.L., Herrinton L.J., Schwartz S.M., et al. 1995. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology 6 : 181–183. [CrossRef] [PubMed] [Google Scholar]
  • Taku K, Lin N, Cai D et al. 2010. Effects of soy isoflavone extract supplements on blood pressure in adult humans : systematic review and meta-analysis of randomized placebo-controlled trials. J. Hypertension 28 : 1971–1982. [CrossRef] [Google Scholar]
  • Tang AL, Walker KZ, Wilcox G, Strauss BJ, Ashton JF, Stojanovska L. 2010. Calcium absorption in Australian osteopenic post-menopausal women : an acute comparative study of fortified soymilk to cows’ milk. Asia Pac. J. Clin. Nutr. 19 : 243–249. [PubMed] [Google Scholar]
  • Travis RC, Allen NE, Appleby PN, et al. 2008. A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int. J. Cancer 122 : 705–710. [CrossRef] [PubMed] [Google Scholar]
  • Urpi-Sarda M, Morand C, Besson C, et al. 2008. Tissue distribution of isoflavones in ewes after consumption of red clover silage. Arch. Biochem. Biophys. 476 : 205–210. [CrossRef] [PubMed] [Google Scholar]
  • USDA (U.S. Department of Agriculture, Agricultural Research Service). 2008. USDA Database for the Isoflavone Content of Selected Foods, Release 2.0. Disponible sur : http://www.ars.usda.gov/SP2UserFiles/Place/80400525/Data/isoflav/Isoflav_R2.pdf [Google Scholar]
  • USDA (US Department of Agriculture, Agricultural Research Service, Nutrient Data Laboratory). 2015. USDA National Nutrient Database for Standard Reference, Release 28. Version Current : September 2015. Disponible sur : https://ndb.nal.usda.gov/ndb/foods/show/4846?fgcd=&manu=&lfacet=&format=&count=&max=35&offset=&sort=&qlookup=16109 [Google Scholar]
  • Vandenplas Y, Gutierrez Castrellon P, Rivas R, et al. 2014. Safety of soya-based infant formulas in children. Br. J. Nutr. 111 : 1340–1360. [CrossRef] [PubMed] [Google Scholar]
  • Wang H-J, Murphy PA. 1996. Mass balance study of isoflavones during soybean processing. J. Agric. Food Chem. 44 : 2377–2383. [CrossRef] [Google Scholar]
  • Weggemans RM, Trautwein EA. 2003. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans : a meta-analysis. Eur. J. Clin. Nutr. 57 : 940–946. [CrossRef] [PubMed] [Google Scholar]
  • WHO. 1985. Energy and Protein Requirements : Report of a Joint FAO/WHO/UNU Expert Consultation. Geneva : WHO Technical Report Series 724. [Google Scholar]
  • WHO. 2007. Protein and amino acid requirements in human nutrition : Report of a Joint WHO/FAO/UNU Expert Consultation. Geneva : WHO Technical Report Series 935. [Google Scholar]
  • World Cancer Research Fund International. 2014. Continuous Update Project Report : Diet, Nutrition, Physical Activity, and Breast Cancer Survivors. 2014. Disponible sur : www.wcrf.org/sites/default/files/Breast-Cancer-Survivors-2014-Report.pdf. [Google Scholar]
  • Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. 2002. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23 : 1491–1496. [CrossRef] [PubMed] [Google Scholar]
  • Wu AH, Yu MC, Tseng CC, Pike MC. 2008. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 98 : 9–14. [CrossRef] [PubMed] [Google Scholar]
  • Wu AH, Spicer D, Garcia A, et al. 2015. Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density. Cancer Prev. Res. (Phila) 8 : 942–951. [CrossRef] [PubMed] [Google Scholar]
  • Yamamoto S., Sobue T., Kobayashi M., et al. 2003. Soy, isoflavones and breast cancer risk in Japan. J. Natl. Cancer Inst. 95 : 906–913. [CrossRef] [PubMed] [Google Scholar]
  • Zhan S, Ho SC. 2005. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr. 81 : 397–408. [CrossRef] [PubMed] [Google Scholar]
  • Zhang YF, Kang HB, Li BL, Zhang RM. 2012. Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac. J. Cancer. Prev. 13 : 479–482. [CrossRef] [PubMed] [Google Scholar]
  • Zhao Y, Martin BR, Weaver CM. 2005. Calcium bioavailability of calcium carbonate fortified soymilk is equivalent to cow’s milk in young women. J. Nutr. 135 : 2379–2382. [CrossRef] [PubMed] [Google Scholar]
  • Ziegler RG, Hoover RN, Pike MC, et al. 1993. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst. 85 : 1819–1827. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.